secwatch.observer — SEC 8-K summary
======================================

Issuer:     SELECTIS HEALTH, INC. (GBCS)
CIK:        0000727346
Form:       8-K
Filed at:   2022-09-20T23:59:59+00:00
Accession:  0001493152-22-026352
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Selectis Health Q2 revenue up 91% to $11.5M; net income $1.0M vs loss year ago
------------------------------------------------------------------------------

- Q2 2022 revenue $11.5M (record), up 91% YoY; net income $1.0M ($0.34 per share) vs net loss of $0.7M.
- Q1 2022 revenue $10.1M, up 75% YoY; net income $0.2M ($0.07 per share) vs $0.2M.
- Company became current on SEC filings by filing Q1 and Q2 2022 10-Qs, resolving prior delays.
- Appointed Christine Lucus as CFO and David Furstenberg to board; cash $3.9M at June 30, 2022.
- Operating cash flow improved to $0.1M for six months ended June 30, 2022 vs ($0.6M) year ago.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/727346/000149315222026352/0001493152-22-026352-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/727346/000149315222026352/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-026352

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer